E28: Dr. Sarah Hayward-Small - Cancer Biology and Mesothelioma Research

Education and Workforce Development Part 5

Show Notes

We apologise for some of the sound towards the end of this episode as we experienced internet connectivity problems.
Discussion around Cancer Biology.
Jo McNamara and Naman Julka-Anderson catch up with Dr. Sarah Hayward-Small as part of the Education and Workforce Development series (Part 5).

To use this podcast as CPD, look at these reflection points: 

1) What is mesothelioma? What are the risks and causes?

2) As a health professional, how can you improve the cancer diagnostic experience?

3) What are the pros and cons of cancer screening programmes?

Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:

Support and Mesothelioma Diagnosis: https://www.blf.org.uk/support-for-you/mesothelioma/diagnosis and

https://www.macmillan.org.uk/cancer-information-and-support/mesothelioma/diagnosis

Mesothelioma patient stories: https://www.mesothelioma.uk.com/patient-stories/

Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience: https://pubmed.ncbi.nlm.nih.gov/31179006/

Pros and cons of screening: https://www.nature.com/articles/d41586-020-00841-8

Novel clinical imaging tools to detect asbestos fibres in malignant mesothelioma:

https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/pdf/10.1002/rcm.8906

Headspace analysis of mesothelioma differentiates between different types of mesothelioma:

https://iopscience.iop.org/article/10.1088/1752-7163/abaaff/meta

Needles in haystacks: Identifying asbestos fibres in mesothelioma models: https://pubs.rsc.org/en/content/articlehtml/2020/ja/d0ja00268b

Please like and subscribe to Rad Chat on your podcast library.

Our links:

Link Tree: https://linktr.ee/radchat 

Facebook: https://www.facebook.com/RadChatPodcast/ 

Instagram: https://www.instagram.com/rad__chat/ 

LinkedIn: https://uk.linkedin.com/company/radtalk 

Tik Tok: https://www.tiktok.com/@rad_chat 

Twitter: https://twitter.com/rad__chat?lang=en 

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  

You must not use any images, audio, video, graphics or clips separately from their accompanying context.  

Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

What is Rad Chat?

Rad Chat is a forward-thinking global knowledge hub where healthcare professionals can advance their knowledge and expertise in radiotherapy and oncology by utilising the award winning, first therapeutic radiographer led oncology podcast and social media channels.

We're empowering healthcare professionals worldwide by providing free, CPD-accredited radiotherapy and oncology education, by sharing real-world experience, expert insights, best practice and patient perspectives, we're helping healthcare professionals’ advance cancer care and improve patient outcomes.